Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The injectable hydrogel effectively speeds up chronic wound healing.

Dermatopathia pigmentosa reticularis causes skin discoloration, hair loss, and nail problems.

PAD type III enzyme is specific to rat skin and hair follicles.

Regulatory measures are needed to ensure safe production and use of platelet concentrates in Brazil.

PGD2 stops hair growth and is higher in bald men with AGA.

Phosphatidic acid may help hair grow by affecting cell growth pathways.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

PDF2 senses specific lipids and regulates root growth and gene expression in Arabidopsis.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

CDPDFM can improve acne symptoms in rabbit ears.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

BM-PHA is as effective and safe as Restylane Perlane for improving nasolabial folds with minor side effects.

PRP injections may improve hair thickness and density in female hair loss patients.

p2y5, now called LPA6, is a receptor important for human hair growth.

Two L-PRP treatments improve hair density in mild to moderate alopecia.

PPD in mehendi can cause serious health problems and needs regulation.

Deep Brain Stimulation helps manage Parkinson's symptoms when medication isn't enough.

LPA 4 helps control blood and lymph vessel development in zebrafish.

The hydrogel speeds up diabetic wound healing and reduces scarring.

Using 5-aminolevulinic acid photodynamic therapy for hair loss didn't increase hair growth but slightly reduced scalp oiliness, and it was safe with mild side effects.

The new controlled release PRP therapy shows promise for hair growth in women.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.